EMPOWERING NEW VISIONARIES
Current Projects
feature-img-4

A biotech company formed with MGH with a technology for cancer chemo- and immunotherapy treatments that increases drug efficacy at significantly lower concentrations.

A biotech company developing treatments for drug, alcohol and tobacco addiction

 

A biotech company formed with Mayo Clinic with a unique method of binding currently available immunotherapy agents with protein-bound chemotherapy drugs that improves drug efficacy, increases overall survival time and reduces side effects.

NTC of China

A company that performs metal coating services in seven factories located throughout China.

A biotech company that is developing encapsulated islet implants for juvenile diabetes. The technology is also applicable for orthopedic uses as well as other indwelling devices in the body.

Medical devices and technologies. Product lines include devices to alleviate FJS – facet joint osteoarthritis (spinal arthritis) and an intrahospital equipment transport system that promotes patient/staff safety. Gorlin started the company with his son. NASDAQ: MDVX

Cancer treatment. Formerly ConKwest, was essentially bankrupt until Gorlin invested $500,000, changed the board and restarted the company. Private funding with Patrick Soon-Shiong. Public offering in Aug. 2015 at a valuation of $1.8 billion. NASDAQ: NK

GET IN TOUCH

Contact Us

Alpine Bank Building. 600 E. Hopkins Ave., #302. Aspen CO 81611
agardner@gorlincompanies.com

to top button